Dr. Kalaycio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273- Is this information wrong?
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1992 - 1994- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1991 - 1992
UPMC Medical Education/MercyResidency, Internal Medicine, 1988 - 1991
West Virginia University School of MedicineClass of 1988
Certifications & Licensure
OH State Medical License 1990 - 2024
NY State Medical License 2002 - 2022
MI State Medical License 2002 - 2021
PA State Medical License 1990 - 2021
IL State Medical License 2002 - 2020
CA State Medical License 2002 - 2020
FL State Medical License 2016 - 2018- American Board of Internal Medicine Hematology
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
- Join now to see all
Clinical Trials
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2001 Jun 01
- S0902 Bendamustine and Rituximab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Not Responded to Previous Treatment Start of enrollment: 2009 Sep 01
- Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL) Start of enrollment: 2008 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- What do atomic bomb survivors teach us about therapy-free remission in people with chronic myeloid leukaemia?Tomas Radivoyevitch, Robert Peter Gale, Matt E Kalaycio> ;Leukemia. 2024 Jan 1
- Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.Betty K Hamilton, Lisa A Rybicki, Hong Li, Taylor Lucas, Donna Corrigan, Matt Kalaycio, Ronald Sobecks, Rabi Hanna, Seth J Rotz, Robert M Dean, Aaron T Gerds, Deepa Ja...> ;Blood Advances. 2023 Aug 22
- A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease.Sagar S Patel, Sanghee Hong, Lisa Rybicki, Stephanie Farlow, Jane Dabney, Matt Kalaycio, Ronald Sobecks, Navneet S Majhail, Betty K Hamilton> ;Transplantation and Cellular Therapy. 2023 Jul 1
- Join now to see all
Journal Articles
- Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell TransplantationDeepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature
- Neutropenic Fever During Peripheral Blood Progenitor Cell Mobilization Is Associated with Decreased CD34+ Cell Collection and Increased Apheresis Collection DaysMat Kalaycio, Robert Dean, Jack Khouri, Brad Pohlman, Aleksandr Lazaryan, Edward Copelan, Steven Andresen, Ronald Sobecks, Hien Liu, Journal of Clinical Apheresis
Abstracts/Posters
- Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary EraMatt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat AnalysisMatt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Survival Outcomes of Patients with Therapy-Related Acute Myeloid Leukemia in the United States2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- TP53 Mutations in Myeloid Neoplasm Patients with and without Significant Personal and Family History of CancerClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Simmons Cancer Center’s Dr. John Sweetenham to Chair National Comprehensive Cancer Network Board of DirectorsApril 5th, 2022- Why Coronavirus-Related Delays in Cancer Screenings Are Concerning, According to ExpertsMarch 19th, 2021
- How the Pandemic Will Affect the Future of Cancer Care: 3 Specialists Weigh InAugust 12th, 2020
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Cleveland ClinicCleveland, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
